Skip to main content

Table 6 Comparison of pharmacological treatments at the time of the index AMI event and at interview 2 years after AMI

From: Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome

  At AMI At interview
Aspirin n = 200 (%) 199 (99.5) 183 (91.5)
Beta-blocker n = 200 (%) 187 (93.5) 166 (83.0)
ACE-inhibitor or Angiotensin receptor blocker n = 200 (%) 177 (88.5) 153 (76.5)
Statin n = 200 (%) 193 (96.5) 177 (88.5)
Clopidogrel/prasugrel n = 200 (%) 179 (89.5) 11 (5.5)
  1. AMI acute myocardial infarction, ACE angiotensin-converting enzyme